EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Treatment with Minicircle DNA Expressing a FGF23 Fragment in a Clinically relevant Mouse Model of X‐Linked Hypophosphatemic Rickets

Huixiao Wu, Wanyi Zhao, Xinyu Chen, Yanzhou Wang, Shuoshuo Wei, Bo Xiang, Yingzhou Shi, Zongyue Li, Yangyang Yao, Jin Xie, Renyuan Qiu, Meng Shu und 9 weitere

Advanced Science · 2026

DOI: 10.1002/advs.202508870 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Huixiao Wu und 20 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging, Ministry of Education; Department of Endocrinology and Metabolism, Shandong …. Hauptthemen laut MEDLINE: Familial Hypophosphatemic Rickets, Genetic Therapy, Fibroblast Growth Factors, DNA, Circular. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Major Science and Technology Projects of China, Academic promotion program of Shandong First Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

X‐linked hypophosphatemic rickets (XLHR) is a rare X‐linked dominant skeletal dysplasia caused by phosphate regulating endopeptidase homolog X‐linked (PHEX) gene mutation. Until now, the pathogenic role of PHEX has not been fully determined, and there has been no radical cure for XLHR. In the previous study, a novel PHEX variant (c.T1349C; p.L450P) is identified in a child with XLHR. The present study aims to reveal its pathogenic role and evaluate the therapeutic effects of the minicircle (MC)‐DNA in XLHR. In vitro, the wildtype and mutant plasmids are introduced into HEK293 cells. In vivo, a new knock‐in XLHR mouse model carrying the novel variant is established. Furthermore, this study makes the first attempt to perform gene therapy using a MC‐DNA vector expressing a fragment of FGF23 (amino acids 180‐251) in the Phex ‐T1349C mice. The new mouse model demonstrates the clinical manifestations of XLHR seen in the patient, including a gene dosage effect. Furthermore, MC‐DNA is found to slightly increase blood phosphorus levels, significantly decrease serum alkaline phosphatase levels, and improve bone mineralization without apparent adverse effects for at least 6 weeks. This study suggests MC‐DNA as a promisingly safe and effective therapeutic strategy to treat XLHR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Familial Hypophosphatemic RicketsGenetic TherapyFibroblast Growth FactorsDNA, CircularAnimalsFibroblast Growth Factor-23MiceDisease Models, AnimalHumansPHEX Phosphate Regulating Neutral EndopeptidaseHEK293 CellsMaleGene Knock-In Techniques

Stichwörter der Autor:innen

PHEXXLHRgene therapyminicircle DNAmouse model

Substanzen

Fibroblast Growth Factor-23Fgf23 protein, mouseFGF23 protein, humanFibroblast Growth FactorsPHEX Phosphate Regulating Neutral EndopeptidaseDNA, Circular

Autor:innen und Institutionen

  • Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging, Ministry of Education; Department of Endocrinology and Metabolism, Shandong Provincial Hospital Affiliated to Shandong First Medical University, J…
  • Shandong Provincial Research Center for Stem Cells and Gene Therapy of Endocrine Metabolic Diseases, Jinan, 250021, P. R. China.
  • Institute of Endocrinology, Shandong Academy of Clinical Medicine, Jinan, 250021, P. R. China.
  • Shandong Clinical Medical Center of Endocrinology and Metabolism, Jinan, 250021, P. R. China.
  • Department of Pediatric Orthopedics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, P. R. China.
  • Department of Radiology, Shandong Rongjun General Hospital, Jinan, 250013, P. R. China.

ORCID-Profile: Chao Xu

Förderung

  • National Natural Science Foundation of China
  • National Major Science and Technology Projects of China
  • Academic promotion program of Shandong First Medical University
  • Taishan Scholar Project

Zitieren

APA

Wu, H., Zhao, W., Chen, X., Wang, Y., Wei, S., Xiang, B., Shi, Y., Li, Z., Yao, Y., Xie, J., Qiu, R., Shu, M., Xu, S., Chen, P., Chen, Z., Wu, Y., Xia, W., Gao, L., Song, Y., …, & Xu, C. (2026). Treatment with Minicircle DNA Expressing a FGF23 Fragment in a Clinically relevant Mouse Model of X‐Linked Hypophosphatemic Rickets. Advanced Science. https://doi.org/10.1002/advs.202508870

Vancouver

Wu H, Zhao W, Chen X, Wang Y, Wei S, Xiang B, et al. Treatment with Minicircle DNA Expressing a FGF23 Fragment in a Clinically relevant Mouse Model of X‐Linked Hypophosphatemic Rickets. Advanced Science. 2026. doi:10.1002/advs.202508870

BibTeX
@article{Wu2026,
  author = {Wu, Huixiao and Zhao, Wanyi and Chen, Xinyu and Wang, Yanzhou and Wei, Shuoshuo and Xiang, Bo and Shi, Yingzhou and Li, Zongyue and Yao, Yangyang and Xie, Jin and Qiu, Renyuan and Shu, Meng and Xu, Shuo and Chen, Ping and Chen, Zhiying and Wu, Yingjie and Xia, Weibo and Gao, Ling and Song, Yongfeng and Zhao, Jiajun and Xu, Chao},
  title = {Treatment with Minicircle DNA Expressing a FGF23 Fragment in a Clinically relevant Mouse Model of X‐Linked Hypophosphatemic Rickets},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202508870}
}
Kostenlos starten →